Clean medicine developer Genexa roped in Unilever for its $60m series A round while Krafton led storytelling platform developer Pratilipi's $48m series D.
Funding US-based organic medicine brand Genexa closed a $60m series A round yesterday that included Unilever Ventures, the corporate venturing arm of consumer foods producer Unilever. The round was led by Jared Stein, managing partner at private equity firm Monogram Capital Partners, and also featured Verlinvest, Northcastle Partners, Point King Capital and angel investors including…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.